NASDAQ: BEATHeartbeam Inc Stock
$2.52+0.02 (+0.8%)
Updated Mar 22, 2023
BEAT Price
$2.52
Fair Value Price
N/A
Market Cap
$20.75M
52 Week Low
$1.12
52 Week High
$6.74
P/E
-1.59x
P/B
8.74x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$12.96M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.7
Operating Cash Flow
-$10M
Beta
0.67
Next Earnings
May 11, 2023
Ex-Dividend
N/A
Next Dividend
N/A
BEAT Overview
HeartBeam, Inc., provides telemedicine solutions to detect and monitor cardiac disease remotely (outside a healthcare facility). Its product is a credit card-sized electrocardiogram machine and a cloud-based diagnostic software system. HeartBeam was incorporated in 2015 and is headquartered in Santa Clara, CA.
Zen Score
–
Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BEAT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BEAT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BEAT is poor value based on its book value relative to its share price (8.74x), compared to the US Health Information Services industry average (3.44x)
P/B vs Industry Valuation
BEAT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BEAT due diligence checks available for Premium users.
Be the first to know about important BEAT news, forecast changes, insider trades & much more!
BEAT News
Valuation
BEAT fair value
Fair Value of BEAT stock based on Discounted Cash Flow (DCF)
Price
$2.52
Fair Value
$4.19
Undervalued by
39.91%
BEAT is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BEAT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.59x
Industry
3.81x
Market
22.44x
BEAT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
8.74x
Industry
3.44x
BEAT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BEAT's financial health
Profit margin
Revenue
$0.0
Net Income
-$3.7M
Profit Margin
0%
BEAT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$4.0M
Liabilities
$1.7M
Debt to equity
0.7
BEAT's short-term assets ($4.04M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BEAT's short-term assets ($4.04M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BEAT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.0M
Investing
$0.0
Financing
$0.0
BEAT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BEAT vs Health Information Service Stocks
Heartbeam Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.